Stocktoria
DNA X, Inc. SONM
Nasdaq · XNAS · stock · Telephone & Telegraph Apparatus · website · IPO 2019-05-10
DNA X, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | $58.3M | $93.6M | $69.8M | $54.6M |
| Gross profit | — | $9.9M | $19.3M | $11.6M | $6.4M |
| R&D expense | — | $14.2M | $1.8M | $8.0M | $17.7M |
| Operating income | -$5.4M | -$3.1M | $513,000 | -$14.3M | -$38.0M |
| Interest expense | $945,000 | — | — | $97,000 | — |
| Income tax | -$1.1M | $226,000 | $374,000 | $184,000 | $167,000 |
| Net income | -$20.7M | -$33.6M | -$90,000 | -$14.1M | -$38.6M |
| EPS (diluted) | $-28.58 | $-128.37 | $-0.02 | $-0.49 | — |
| Operating cash flow | -$23.5M | -$8.5M | -$4.1M | -$12.4M | -$38.5M |
| Free cash flow | — | -$8.7M | -$4.1M | -$12.4M | -$38.5M |
| Cash & equivalents | $1.3M | $5.3M | $9.4M | $13.2M | $11.2M |
| Inventory | — | $10.6M | $6.5M | $3.9M | $5.5M |
| Total assets | $43.9M | $39.7M | $56.0M | $53.7M | $41.1M |
| Total liabilities | $50.6M | $45.4M | $33.7M | $33.6M | $22.5M |
| Shareholders' equity | -$8.0M | -$5.7M | $22.4M | $20.0M | $18.6M |
Source: SEC EDGAR filings · CIK 0001178697 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.